Found: 7
Select item for more details and to access through your institution.
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
- Published in:
- AIDS & Behavior, 2022, v. 26, n. 7, p. 2203, doi. 10.1007/s10461-021-03563-8
- By:
- Publication type:
- Article
Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1020, doi. 10.1111/bcp.15538
- By:
- Publication type:
- Article
Medication burden and clustering in people living with HIV undergoing therapeutic drug monitoring.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 11, p. 4432, doi. 10.1111/bcp.14869
- By:
- Publication type:
- Article
The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries.
- Published in:
- Microorganisms, 2021, v. 9, n. 8, p. 1648, doi. 10.3390/microorganisms9081648
- By:
- Publication type:
- Article
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 1, p. 103, doi. 10.1007/s40262-020-00916-9
- By:
- Publication type:
- Article
Sustained virological response with 16‐week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post‐transplant severe HCV recurrence in HIV.
- Published in:
- Transplant Infectious Disease, 2019, v. 21, n. 6, p. N.PAG, doi. 10.1111/tid.13165
- By:
- Publication type:
- Article
Lower dolutegravir plasma concentrations in HIV-positive patients receiving valproic acid.
- Published in:
- 2018
- By:
- Publication type:
- Case Study